BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30610616)

  • 1. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma.
    Kim YA; Park KK; Lee SJ
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
    Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
    Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
    Ferro A; Saccu G; Mattivi S; Gaido A; Herrera Sanchez MB; Haque S; Silengo L; Altruda F; Durazzo M; Fagoonee S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma.
    Plissonnier ML; Herzog K; Levrero M; Zeisel MB
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30380697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.
    Cao P; Jin Q; Feng L; Li H; Qin G; Zhou G
    Semin Cancer Biol; 2021 Oct; 75():136-152. PubMed ID: 32931952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.
    Klingenberg M; Matsuda A; Diederichs S; Patel T
    J Hepatol; 2017 Sep; 67(3):603-618. PubMed ID: 28438689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
    Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
    Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
    Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma.
    Costanzi E; Simioni C; Varano G; Brenna C; Conti I; Neri LM
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
    Lin YH; Wu MH; Yeh CT; Lin KH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.
    Zhang B; Han S; Feng B; Chu X; Chen L; Wang R
    Exp Mol Med; 2017 Feb; 49(2):e293. PubMed ID: 28186085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
    Cao C; Zhang T; Zhang D; Xie L; Zou X; Lei L; Wu D; Liu L
    Oncogene; 2017 Feb; 36(8):1112-1122. PubMed ID: 27530352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.